Phenol Derivatives Obtained from Grape Seed Extract Show Virucidal Activity against Murine Norovirus

Abstract

Human noroviruses are the most common pathogens known to cause acute gastroenteritis, a condition that can lead to severe illness among immunocompromised individuals such as organ transplant recipients and the elderly. To date, no safe and effective vaccines or therapeutic agents have been approved for treating norovirus infections. Therefore, we aimed to demonstrate the virucidal activity of grape seed extract (GSE), which contains >83% proanthocyanidins, against murine norovirus (MNV), a surrogate for human norovirus. GSE showed virucidal activity against MNV in a dose- and time-dependent manner. Atomic force microscopic analysis showed viral particle aggregates after treatment of MNV with GSE. MNV treated with 50 µg/mL of GSE for 10 min resulted in the absence of pathogenicity in an animal model of infection, indicating that GSE has irreversible virucidal activity against MNV particles. Thus, GSE may aid in the development of treatments for norovirus infections.

Bacillaceae serine proteases and Streptomyces epsilon-poly-l-lysine synergistically inactivate Caliciviridae by inhibiting RNA genome release

“…After the final collection, all mice ( n = 20) were sacrificed via intraperitoneal injection of excess sodium pentobarbital (150 mg/kg of mice). The infectious MNV titer in feces was determined per a previously-reported plaque assay protocol using 1.5% ( w/v ) SeaPlaque™ agarose (Lonza, Rockland, ME, USA) 40 .…”